Patient surveillance after cancer treatment

Patient Surveillance After Cancer Treatment covers the history of cancer patient surveillance after curative-intent treatment, the rationale, the methodologies used in the past and at present, the methodologies that will probably emerge in the future, the costs of surveillance, the definitions of various termsused in the field, and how those who are interested in the topic can get moreinformation about it from the internet.The audience includes all oncologists, cancer researchers, medical economistsand policy makers in government and insurance companies, and finally, interested patients. INDICE: Section I: Concepts Chapter 1. Overview Author – Frank Johnson Chapter 2. Assessment of performance and costs of surveillance tests (direct and indirect costs) Authors – Kathy Virgo and Frank Johnson Chapter 3. Costs and charges of follow-up tests currently employed (direct and indirect costs) Authors – Frank Johnson and Kathy Virgo Chapter 4. How are surveillance strategies chosen Author – Frank Johnson Section II: Current Practice Chapter 5. Carcinoma of the upper aerodigestive tract Chapter 6. Carcinoma of the thyroid Chapter7. Carcinoma of the lung Chapter 8. Carcinoma of the esophagus Chapter 9. Carcinoma of the stomach Chapter10. Carcinoma of the pancreas Chapter 11. Carcinoma of the liver and biliary tract Chapter 12. Carcinoma of the colon and rectum Chapter 13. Carcinoma of the anus Chapter 14. Soft tissue sarcoma Chapter 15. Osteogenic sarcoma Chapter 16. Cutaneous melanoma Chapter 17. Carcinoma of the breast Chapter 18. Carcinoma of the endometrium Chapter 19. Carcinoma of the uterine cervix Chapter 20. Carcinoma of the vagina Chapter 21. Carcinoma of the ovary Chapter 22. Carcinoma of the kidney Chapter 23. Carcinoma of the urinary bladder Chapter 24. Carcinoma of the prostate Chapter 25. Carcinoma of the testis Chapter 26. Lymphoma – Conventional treatment Chapter 27. Lymphoma – High-dose therapy plus stem cell rescue Chapter 28. Leukemia Chapter 29. Myeloma Chapter 30. Glioma of the central nervous system Section III: Horizons Chapter 31. Monitoring and managing long-term effects of treatment Author – Craig Earle ± radiation oncologist ± surgeon Chapter 32. How molecular genetics may affect surveillance strategies in the future Author – Paul Goodfellow Chapter 33. Using administrative data to conduct research Kathy Virgo – who should we ask to write this chapter? Chapter 34. Decision analysis Author – Job Kievit

• ISBN: 978-1-60327-968-0
• Editorial: Humana
• Encuadernacion: Cartoné
• Páginas: 950
• Fecha Publicación: 28/06/2012
• Nº Volúmenes: 1
• Idioma: Inglés